Blood pressure changes Wegovy may cause low blood pressure as a side effect, especially in people taking blood pressure medications
When to Consider Peptide Therapy (and When Not To) Peptides May Be Right If You: Struggle with recovery , fatigue, or muscle loss Are over 40 and experiencing age-related decline Have recurring joint pain or slow-healing injuries Want a natural alternative to HGH or NSAIDs You Should Avoid Peptides If: You have a history of cancer (especially hormone-sensitive types) You are pregnant or breastfeeding You have untreated autoimmune disease We take a conservative approachensuring every patient is screened, monitored, and educated
Genet Dev
While semaglutide targets only GLP-1 receptors, tirzepatide is a dual agonist that targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, adding a second metabolic pathway to the mechanism
*Note: Branded versions like Wegovy are FDA-approved for weight loss
Starting July 1, Caremark will prioritize Wegovy on its formularies or lists of covered drugs making it the preferred GLP-1 drug for obesity